Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Treatment-Refractory NTM-LD (14 minutes)

Watch experts discuss how they manage patients with refractory/relapsing nontuberculous mycobacterial lung diseases
Stephen Ruoss, MD
Kevin L. Winthrop, MD, MPH ID
Released: February 14, 2020 Expiration: No longer available for credit

This program is divided into several short segments which you can step through using the Video Chapters widget.

Related Content

On-demand webcast featuring an expert panel with insight on new data presented at ECCO 2022 for Crohn disease and ulcerative colitis from Clinical Care Options (CCO)

Uma Mahadevan, MD Bruce E. Sands, MD, MS Physicians: maximum of 0.75 AMA PRA Category 1 Credits Released: May 19, 2022 Expired: May 18, 2023

Clinical Care Options (CCO) presents expert commentary on new data in Crohn disease and ulcerative colitis from ECCO 2022

Bruce E. Sands, MD, MS Released: May 13, 2022

Expert slides from Clinical Care Options (CCO) on new data from ECCO 2022 17th Congress Meeting in patients with Crohn disease and ulcerative colitis

Uma Mahadevan, MD Bruce E. Sands, MD, MS Released: May 6, 2022

Expert commentary on the role of HLA-DQA1*05 in patients with IBD receiving anti-TNF therapy, from Clinical Care Options (CCO)

Marla Dubinsky, MD Bruce E. Sands, MD, MS Released: March 2, 2022

Video Chapters


Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
American Thoracic Society Logo
Supported by an educational grant from
Insmed

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings